What is the intrinsic value of Gujarat Terce Laboratories Ltd and is it undervalued?

As of 08 September 2026, Gujarat Terce Laboratories Ltd's intrinsic value is 35.70, which is 0.00% lower than the current market price of 35.70, suggesting the stock is overvalued. Calculated using the PE ratio method factoring in ROE (30.2 %), book value (12.5), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Gujarat Terce Laboratories Ltd?

Gujarat Terce Laboratories Ltd is trading at 35.70 as of 08 September 2026, with a FY2026-2027 high of 59.8 and low of 29.0. The stock is currently near its 52-week low. Market cap stands at 27.8 Cr..

How does Gujarat Terce Laboratories Ltd's P/E ratio compare to its industry?

Gujarat Terce Laboratories Ltd has a P/E ratio of 12.5, which is below the industry average of 44.88. Trading at a steep discount to peers could signal a value opportunity.

Is Gujarat Terce Laboratories Ltd financially healthy?

Key indicators: ROCE of 39.2 % indicates efficient capital utilization. Dividend yield is 0.00 %.

Is Gujarat Terce Laboratories Ltd profitable and how is the profit trend?

Gujarat Terce Laboratories Ltd reported a net profit of -1 Cr in Mar 2025 on revenue of 50 Cr. Compared to 1 Cr in Mar 2022, the net profit shows a declining trend.

Does Gujarat Terce Laboratories Ltd pay dividends?

Gujarat Terce Laboratories Ltd has a dividend yield of 0.00 % at the current price of 35.70. The company is currently not paying meaningful dividends.

Gujarat Terce Laboratories Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹38.51Fairly Valued by 7.87%vs CMP ₹35.70

P/E (12.5) × ROE (30.2%) × BV (₹12.50) × DY (2.00%)

₹35.70Fairly Valued by 0.00%vs CMP ₹35.70

MoS: 0% (Negative)Confidence: 33/100 (Low)Models: 1 Under, 1 Fair, 1 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹29.30	57%	Over (-17.9%)
EV/EBITDA	Enterprise	₹54.83	23%	Under (+53.6%)
Revenue Multiple	Revenue	₹32.23	20%	Fair (-9.7%)
Consensus (3 models)		₹35.70	100%	Fairly Valued

Key Drivers: EPS CAGR -23.9% drags value — could be higher if earnings stabilize.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -23.9%

*Investments are subject to market risks

Analyst Summary

Gujarat Terce Laboratories Ltd operates in the Pharmaceuticals segment, NSE: GUJTERC | BSE: 524314, current market price is ₹35.70, market cap is 27.8 Cr.. At a glance, stock P/E is 12.5, ROE is 30.2 %, ROCE is 39.2 %, book value is 12.5, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹35.70, which is broadly in line with the current market price. On operating trend, latest reported sales are about ₹50 Cr versus the prior period change of 4.8%, while latest net profit is about ₹-1 Cr with a prior-period change of -508.3%. The 52-week range shown on this page is 59.8/29.0, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisGujarat Terce Laboratories Ltd. is a Public Limited Listed company incorporated on 28/03/1985 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CI…

This summary is generated from the stock page data available for Gujarat Terce Laboratories Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Gujarat Terce Laboratories Ltd scores 63/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health63/100 · Moderate

ROCE 39.2% ExcellentROE 30.2% ExcellentD/E 0.59 ModerateInterest Coverage 0.0x RiskyProfitable 2/5 years Inconsistent

Smart Money50/100 · Moderate

Promoter holding at 40.0% Stable

Earnings Quality75/100 · Strong

OPM expanding (-1% → 5%) ImprovingWorking capital: -14 days (improving) Efficient

Quarterly Momentum40/100 · Moderate

Revenue (4Q): -3% YoY FlatProfit (4Q): -143% YoY Declining

Industry Rank85/100 · Strong

P/E 12.5 vs industry 54.6 Cheaper than peersROCE 39.2% vs industry 25.3% Above peersROE 30.2% vs industry 18.4% Above peers3Y sales CAGR: 8% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily.

Share Price and Basic Stock Data

Last Updated: August 25, 2026, 10:19 am

Market Cap	27.8 Cr.
Current Price	35.7
Intrinsic Value	₹35.70
High / Low	59.8/29.0
Stock P/E	12.5
Book Value	12.5
Dividend Yield	0.00 %
ROCE	39.2 %
ROE	30.2 %
Face Value	10.0
PEG Ratio	-0.52

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Gujarat Terce Laboratories Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gujarat Terce Laboratories Ltd	27.8 Cr.	35.7	59.8/29.0	12.5	12.5	0.00 %	39.2 %	30.2 %	10.0
Coral Laboratories Ltd	233 Cr.	654	679/360	12.3	585	0.31 %	11.0 %	7.88 %	10.0
Chandra Bhagat Pharma Ltd	37.6 Cr.	49.9	55.0/29.7	12.3	43.9	0.00 %	12.1 %	9.67 %	10.0
Lincoln Pharmaceuticals Ltd	1,226 Cr.	612	770/440	12.7	378	0.29 %	16.3 %	12.3 %	10.0
Ambalal Sarabhai Enterprises Ltd	203 Cr.	26.5	42.0/23.1	11.4	19.2	0.00 %	9.12 %	6.25 %	10.0
Industry Average	23,072.45 Cr	1,307.39		54.56	215.82	0.36%	25.34%	18.37%	6.02

All Competitor Stocks of Gujarat Terce Laboratories Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	11.90	12.89	10.72	12.03	13.02	12.21	11.89	13.30	12.68	12.32	10.85	12.93	12.29
Expenses	11.77	13.08	11.85	11.48	12.18	11.20	11.81	11.64	11.60	11.27	10.86	11.03	11.16
Operating Profit	0.13	-0.19	-1.13	0.55	0.84	1.01	0.08	1.66	1.08	1.05	-0.01	1.90	1.13
OPM %	1.09%	-1.47%	-10.54%	4.57%	6.45%	8.27%	0.67%	12.48%	8.52%	8.52%	-0.09%	14.69%	9.19%
Other Income	0.08	0.10	0.08	0.08	0.08	0.08	0.07	0.08	0.07	0.09	0.09	0.05	0.13
Interest	0.14	0.17	0.17	0.20	0.16	0.15	0.13	0.13	0.08	0.07	0.05	0.07	0.04
Depreciation	0.07	0.16	0.09	0.09	0.09	0.09	0.09	0.09	0.10	0.10	0.10	0.10	0.10
Profit before tax	0.00	-0.42	-1.31	0.34	0.67	0.85	-0.07	1.52	0.97	0.97	-0.07	1.78	1.12
Tax %		-290.48%	0.00%	0.00%	0.00%	35.29%	14.29%	1.97%	-3.09%	449.48%	-42.86%	21.35%	33.04%
Net Profit	0.00	0.80	-1.31	0.33	0.67	0.54	-0.08	1.48	1.01	-3.39	-0.04	1.40	0.76
EPS in Rs	0.00	1.08	-1.77	0.44	0.90	0.73	-0.11	1.99	1.36	-4.57	-0.05	1.89	0.98

Last Updated: March 3, 2026, 9:22 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 6:50 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	28.84	26.48	25.00	25.29	29.01	31.03	37.54	25.18	40.13	46.78	47.92	50.20	48.39
Expenses	27.89	25.70	24.84	25.21	28.68	30.54	36.86	27.77	39.02	48.94	46.65	46.31	44.32
Operating Profit	0.95	0.78	0.16	0.08	0.33	0.49	0.68	-2.59	1.11	-2.16	1.27	3.89	4.07
OPM %	3.29%	2.95%	0.64%	0.32%	1.14%	1.58%	1.81%	-10.29%	2.77%	-4.62%	2.65%	7.75%	8.41%
Other Income	0.13	0.08	0.19	0.44	0.41	0.32	0.29	0.62	0.31	0.35	0.32	0.31	0.36
Interest	0.41	0.41	0.38	0.31	0.23	0.25	0.29	0.39	0.40	0.72	0.68	0.42	0.23
Depreciation	0.33	0.16	0.19	0.19	0.19	0.21	0.24	0.18	0.28	0.36	0.37	0.38	0.40
Profit before tax	0.34	0.29	-0.22	0.02	0.32	0.35	0.44	-2.54	0.74	-2.89	0.54	3.40	3.80
Tax %	29.41%	72.41%	209.09%	150.00%	15.62%	-25.71%	36.36%	-0.39%	-17.57%	-42.21%	55.56%	128.53%
Net Profit	0.24	0.09	-0.67	-0.01	0.27	0.43	0.28	-2.52	0.87	-1.67	0.24	-0.98	-1.27
EPS in Rs	0.32	0.12	-0.90	-0.01	0.36	0.58	0.38	-3.40	1.17	-2.25	0.32	-1.32	-1.75
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-62.50%	-844.44%	98.51%	2800.00%	59.26%	-34.88%	-1000.00%	134.52%	-291.95%	114.37%	-508.33%
Change in YoY Net Profit Growth (%)	0.00%	-781.94%	942.95%	2701.49%	-2740.74%	-94.14%	-965.12%	1134.52%	-426.48%	406.33%	-622.70%

Gujarat Terce Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

No data available for the compounded sales growth chart.

No data available for the Balance Sheet data table.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	1.38	0.16	0.24	4.58	-0.61	-1.59	-0.16	-0.44	0.03	2.60	3.06	1.71
Cash from Investing Activity +	0.08	-0.13	0.18	1.11	-0.13	-0.27	-0.42	-0.87	0.62	-0.46	0.46	-0.11
Cash from Financing Activity +	-0.73	-1.43	-0.36	-5.39	0.20	1.72	1.83	1.53	-0.12	-4.08	-2.83	0.47
Net Cash Flow	0.73	-1.39	0.06	0.29	-0.55	-0.14	1.24	0.22	0.52	-1.94	0.69	2.08
Free Cash Flow	0.92	0.10	0.23	4.45	-1.01	-2.07	-0.66	-2.55	-0.03	2.53	3.41	1.69
CFO/OP	191%	406%	688%	1,418%	-98%	-219%	0%	-31%	-3%	205%	81%	45%

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	116.56	126.81	123.81	114.31	57.62	53.29	68.16	74.94	49.75	62.34	43.11	36.86
Inventory Days	112.27	142.73	162.86	150.01	126.33	114.69	90.00	136.65	153.90	83.56	81.09	71.03
Days Payable	58.79	88.41	92.30	59.70	110.67	85.26	83.44	104.13	96.22	110.35	97.39	69.87
Cash Conversion Cycle	170.04	181.14	194.37	204.61	73.29	82.72	74.72	107.46	107.43	35.56	26.81	38.02
Working Capital Days	93.78	97.04	110.52	86.74	20.89	27.88	25.18	-14.06	6.82	-20.21	-7.69	-13.89
ROCE %	3.80%	3.39%	0.87%	1.91%	2.95%	5.39%	5.79%	-15.09%	8.26%	-14.80%	9.72%	41.41%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	36.78%	37.01%	37.03%	37.03%	37.03%	37.03%	37.03%	37.03%	37.03%	40.03%	40.03%	40.03%
Public	63.22%	62.99%	62.97%	62.97%	62.97%	62.97%	62.99%	62.96%	62.97%	59.98%	59.97%	59.98%
No. of Shareholders	13,404	13,327	13,203	13,394	13,538	13,710	13,764	13,804	13,812	13,805	13,750	13,755

Shareholding Pattern Chart

No. of Shareholders

Gujarat Terce Laboratories Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-1.32	0.33	-2.25	1.18	-3.40
Diluted EPS (Rs.)	-1.32	0.33	-2.25	1.18	-3.40
Cash EPS (Rs.)	-0.80	0.82	-1.76	1.55	-3.16
Book Value[Excl.RevalReserv]/Share (Rs.)	8.73	9.58	9.25	11.50	10.32
Book Value[Incl.RevalReserv]/Share (Rs.)	8.73	9.58	9.25	11.50	10.32
Revenue From Operations / Share (Rs.)	67.64	64.65	63.05	54.09	33.93
PBDIT / Share (Rs.)	5.65	2.14	-2.44	1.92	-2.65
PBIT / Share (Rs.)	5.13	1.64	-2.93	1.55	-2.89
PBT / Share (Rs.)	4.57	0.73	-3.90	1.01	-3.41
Net Profit / Share (Rs.)	-1.32	0.32	-2.25	1.18	-3.40
PBDIT Margin (%)	8.34	3.30	-3.86	3.54	-7.80
PBIT Margin (%)	7.58	2.54	-4.64	2.85	-8.50
PBT Margin (%)	6.75	1.13	-6.18	1.86	-10.05
Net Profit Margin (%)	-1.94	0.50	-3.57	2.17	-10.00
Return on Networth / Equity (%)	-15.10	3.42	-24.35	10.22	-32.89
Return on Capital Employeed (%)	37.36	10.95	-18.22	8.09	-21.08
Return On Assets (%)	-4.28	1.04	-5.85	3.18	-11.55
Long Term Debt / Equity (X)	0.04	0.13	0.21	0.26	0.05
Total Debt / Equity (X)	0.14	0.54	1.06	0.78	0.59
Asset Turnover Ratio (%)	2.18	1.85	1.67	1.63	1.14
Current Ratio (X)	0.95	0.92	0.96	1.17	1.03
Quick Ratio (X)	0.66	0.59	0.69	0.68	0.70
Inventory Turnover Ratio (X)	13.10	1.80	1.11	1.40	0.95
Interest Coverage Ratio (X)	10.09	2.35	-2.51	3.55	-5.05
Interest Coverage Ratio (Post Tax) (X)	-1.36	1.36	-1.32	3.18	-5.47
Enterprise Value (Cr.)	45.53	43.07	17.60	26.07	8.45
EV / Net Operating Revenue (X)	0.90	0.89	0.37	0.64	0.33
EV / EBITDA (X)	10.87	27.12	-9.74	18.31	-4.30
MarketCap / Net Operating Revenue (X)	0.90	0.81	0.26	0.48	0.20
Price / BV (X)	7.00	5.53	1.80	2.27	0.67
Price / Net Operating Revenue (X)	0.90	0.81	0.26	0.48	0.20
EarningsYield	-0.02	0.01	-0.13	0.04	-0.48

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

[display_about_company_data title=”About the Company – Qualitative Analysis”]

FAQ: Stock data is invalid or not in the correct format.